Comparison of the diagnostic performance of H/M ratio between early and delayed phases for Lewy body disease
نویسندگان
چکیده
OBJECTIVES The aim of the study was to compare the diagnostic performance of early-phase I-metaiodobenzylguanidine (MIBG) scintigraphy with that of delayed-phase imaging in Lewy body disease (LBD). METHODS A retrospective cohort study of ¹²³I-MIBG scintigraphy was carried out in 192 patients who were suspected of having LBD. Clinical diagnosis was obtained using the UK Parkinson's Disease Brain Bank Criteria in some cases or the third report of the Dementia with Lewy bodies Consortium in others. The participants consisted of 81 patients with LBD and 111 nondiseased patients. An injection of 111 MBq of ¹²³I-MIBG was used. Planar images were obtained in an early phase and again in a delayed phase and the heart to mediastinum count ratio was calculated for both phases. Diagnostic performance was compared using a receiver-operator characteristic analysis. The cutoff value was chosen to maximize the Youden index. The sensitivity and specificity of each phase were calculated from the optimal cutoff value. RESULTS The heart to mediastinum ratio of the LBD group (median 1.8 and 1.45 for early and delayed phases, respectively) was significantly lower than that of the nondiseased group (median 2.93 and 3.18 for early and delayed phases, respectively). The area under the receiver-operating characteristic curve was not significantly different between the early and delayed phases (0.871 vs. 0.893; P=0.0914). Sensitivity and specificity were 80.2 and 91% for early-phase imaging (cutoff value at 2.28) and 81.5 and 95.5% (cutoff value at 1.91) for delayed-phase imaging, respectively. CONCLUSION The diagnostic performance of ¹²³I-MIBG scintigraphy was not significantly different between early-phase and delayed-phase imaging.
منابع مشابه
Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The heart-tomediastinum ratio (H/M) in PD and DLB is significantly lower than that in Parkinson’s plus syndromes and Alzheimer’s disease. Although this ra...
متن کاملDevelopment of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
Objective(s): We recently developed a new uptake index method for 123I-metaiodobenzylguanidine (123I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies(DLB). However, the diagnostic accuracy of the uptake index was approximately equal to ...
متن کاملComparison between early and delayed images of 67Ga scintigraphy for evaluation of recurrent lymphoma
Introduction: Despite widespread use of 67Gallium for lymphoma evaluation, timing of imaging after injection is a matter of controversy and to the extent of our knowledge no direct comparison has been made between early and delayed gallium images. We aimed to compare 24 and 48 hours post injection planar gallium imaging for evaluation of lymphoma recurrence. Methods: 255 pa...
متن کاملmetaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
Background: Different studies have found diminished cardiac metaiodobenzylguanidine (MIBG) uptake in Lewy body (LB) related conditions (Parkinson’s disease (PD) and Lewy body dementia (LBD)). However, delayed heart/ mediastinum (d-H/M) ratio diagnostic cutoff points are debated in parkinsonian syndromes. Methods: We performed a monocentric retrospective analysis on 62 consecutive parkinsonian p...
متن کاملDelayed phases of contrast MRI, can it be valuable in multiple sclerosis active phase diagnosis?
Background: Observing the enhancing plaques in magnetic resonance imaging (MRI) is one of the most valuable diagnostic modalities in confirming the diagnosis of multiple sclerosis (MS), its recurrence and for better detection of active disease. Since active lesions discovery can improve designating diffusion in time diagnosis of MS and controlling disease activity, and there is not any definite...
متن کامل